Hancock Whitney Corp Laboratory Corp Of America Holdings Transaction History

Hancock Whitney Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$120.82 - $174.09 $174,705 - $251,734	-1,446 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$167.67 - $188.27 $14.2 Million - $15.9 Million	-84,629 Reduced 98.32%	1,446 $251,000
Q2 2018 Aug 14, 2018	SELL	$160.33 - $189.41 $456,138 - $538,871	-2,845 Reduced 3.2%	86,075 $15.5 Million
Q1 2018 May 15, 2018	SELL	$161.53 - $178.11 $373,134 - $411,434	-2,310 Reduced 2.53%	88,920 $14.4 Million
Q4 2017 Feb 12, 2018	SELL	$147.99 - $163.95 $1.5 Million - $1.66 Million	-10,130 Reduced 9.99%	91,230 $14.6 Million
Q3 2017 Nov 14, 2017	SELL	$149.47 - $160.56 $604,307 - $649,144	-4,043 Reduced 3.84%	101,360 $15.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	105,403	105,403 $16.2 Million

126

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.